XENAZINE Drug Patent Profile
✉ Email this page to a colleague
When do Xenazine patents expire, and what generic alternatives are available?
Xenazine is a drug marketed by Bausch and is included in one NDA.
The generic ingredient in XENAZINE is tetrabenazine. There are twelve drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the tetrabenazine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Xenazine
A generic version of XENAZINE was approved as tetrabenazine by HETERO LABS LTD V on February 3rd, 2016.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for XENAZINE?
- What are the global sales for XENAZINE?
- What is Average Wholesale Price for XENAZINE?
Summary for XENAZINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 179 |
| Clinical Trials: | 6 |
| Patent Applications: | 1,372 |
| Drug Prices: | Drug price information for XENAZINE |
| What excipients (inactive ingredients) are in XENAZINE? | XENAZINE excipients list |
| DailyMed Link: | XENAZINE at DailyMed |
Recent Clinical Trials for XENAZINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| The University of Texas Health Science Center, Houston | Phase 4 |
| H. Lundbeck A/S | Phase 4 |
| William Ondo, MD | Phase 4 |
Pharmacology for XENAZINE
| Drug Class | Vesicular Monoamine Transporter 2 Inhibitor |
| Mechanism of Action | Vesicular Monoamine Transporter 2 Inhibitors |
US Patents and Regulatory Information for XENAZINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bausch | XENAZINE | tetrabenazine | TABLET;ORAL | 021894-001 | Aug 15, 2008 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Bausch | XENAZINE | tetrabenazine | TABLET;ORAL | 021894-002 | Aug 15, 2008 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
